These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6639098)

  • 1. [Experimental studies on the optimal therapeutic mode of intra-arterial infusion of 5-fluorouracil. (2) Concentrations within the tumors and normal tissues and therapeutic and adverse effects of 5-fluorouracil delivered by various routes].
    Ota J
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2362-9. PubMed ID: 6639098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental studies on the optimal therapeutic mode of intra-arterial infusion of 5-fluorouracil. (1) Preparation of an animal model for continuous intra-arterial infusion and comparison of the therapeutic and adverse effects of 5-fluorouracil delivered by various modes].
    Ota J
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2353-61. PubMed ID: 6639097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental study of 5-FU + leucovorin therapy by continuous arterial infusion].
    Mori T
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2838-41. PubMed ID: 2789495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Invention of a tumor-selective 5-fluorouracil derivative named S-1 by biochemical modulation of 5-fluorouracil].
    Shirasaka T; Shimamoto Y; Kato T; Fukushima M
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):371-84. PubMed ID: 9492831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of continuous venous infusion of 5-FU and FT-207 under total parenteral nutrition].
    Tane S; Ogawa Y; Kido Y; Naruko M; Niwa H; Abe Y; Kobayashi M; Mori T
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2947-53. PubMed ID: 3094454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study on adequate 5-FU dose and flow volume for continuous arterial liver infusion].
    Mori T; Iwasaki Y; Takahashi K; Takahashi T
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1547-9. PubMed ID: 1530305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antitumor activity and function of S-1, a new oral tegafur-based formulation].
    Fukushima M
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():19-26. PubMed ID: 16897968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In-vivo 19F-MRS study of 5-fluorouracil (5-FU) metabolism on tumors].
    Harada M; Nishitani H; Shirahama T; Koga K; Miura I
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):75-80. PubMed ID: 1899014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [5-Fluorouracil concentration in various tissues from cancer patients after oral administration of 5-fluorouracil].
    Nakamura T; Hashimoto I; Sawada Y; Mikami J; Yoshimoto M; Nishidai H; Nakanishi Y; Kashi Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):1037-48. PubMed ID: 6721512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic fibrosis does not affect the pharmacokinetics of 5-fluorouracil in rats.
    Nagata M; Hidaka Y; Hatakeyama K; Kawano Y; Iwakiri T; Okumura M; Arimori K
    Biopharm Drug Dispos; 2011 Mar; 32(2):126-30. PubMed ID: 21341281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoropyrimidine chemotherapy in a rat model: comparison of fluorouracil metabolite profiles determined by high-field 19F-NMR spectroscopy of tissues ex vivo with therapy response and toxicity for locoregional vs systemic infusion protocols.
    Lutz NW; Naser-Hijazi B; Koroma S; Berger MR; Hull WE
    NMR Biomed; 2004 May; 17(3):101-31. PubMed ID: 15137037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats.
    Shirasaka T; Shimamoto Y; Fukushima M
    Cancer Res; 1993 Sep; 53(17):4004-9. PubMed ID: 7689420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Continuous intraarterial infusion of 5-fluorouracil plus leucovorin for liver metastases from colorectal cancer].
    Shida H; Ban K; Matsumoto M; Ishihara S; Noma M; Ota M; Higashi H; Kitazaki M; Masuda K; Imanari T
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):221-5. PubMed ID: 7857096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Distribution of 5-FU in rat plasma and liver tissue after local 5-FU infusion].
    Zheng JL; Liang LJ; Hu WJ; Shen SL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):823-7. PubMed ID: 18504211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Validity of two-hour continuous hepatic arterial infusion chemotherapy with low-dose 5-FU for unresectable liver metastasis from colorectal cancer].
    Kosaka K; Nishino H; Yamada N; Nishihara T; Ohira M; Hirakawa K
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1647-50. PubMed ID: 14619485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An experimental study on portal infusion of 5-fluorouracil].
    Ishida H; Iwama T; Nishioka Y; Endo S; Okubo Y; Imajo M; Otomo M; Mishima Y
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1884-8. PubMed ID: 1877831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue distribution and biotransformation of potassium oxonate after oral administration of a novel antitumor agent (drug combination of tegafur, 5-chloro-2,4-dihydroxypyridine, and potassium oxonate) to rats.
    Yoshisue K; Masuda H; Matsushima E; Ikeda K; Nagayama S; Kawaguchi Y
    Drug Metab Dispos; 2000 Oct; 28(10):1162-7. PubMed ID: 10997934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the plasma concentration of 5-fluorouracil and the duration of continuous venous infusion of 5-fluorouracil with an inhibitor of 5-fluorouracil degradation on Yoshida sarcomas in rats.
    Fujii S; Shimamoto Y; Ohshimo H; Imaoka T; Motoyama M; Fukushima M; Shirasaka T
    Jpn J Cancer Res; 1989 Feb; 80(2):167-72. PubMed ID: 2498251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I evaluation of therapy with four schedules of 5-fluorouracil by continuous infusion combined with recombinant interferon alpha.
    Greenblatt MS; Mangalik A; Ferguson J; Elias L
    Clin Cancer Res; 1995 Jun; 1(6):615-20. PubMed ID: 9816023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
    Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C
    Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.